Business News › Markets › Stocks › News

We would like to under promise and over deliver: Rossari Biotech

We understand microbiology or antiviral or anti-corona technology well so we know how to protect from corona so our sanitizers, disinfectants and the antiviral portfolio across segments has done very well, says Sunil Chari, MD, Rossari Biotech. Chari and Edward Menezes, Executive Chairman, Rossari Biotech are in conversation with ETNOW.
Share this Video
Text Size:AAA
Markets Data


This article has been saved